Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings

Shares (Q2 2026)
18,091
Value
$4.43M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of AXSM by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,091$4.43M<0.1%+14,876+462.7%AddedHolders
Q1 20263,215$543.4K<0.1%−15,630−82.9%ReducedHolders
Q4 202518,845$3.44M<0.1%−5,500−22.6%ReducedHolders
Q3 202524,345$2.96M<0.1%−6,250−20.4%ReducedHolders
Q2 202530,595$3.19M<0.1%+15,630+104.4%AddedHolders
Q1 202514,965$1.75M<0.1%+400+2.7%AddedHolders
Q4 202414,565$1.23M<0.1%00.0%UnchangedHolders
Q3 202414,565$1.31M<0.1%00.0%UnchangedHolders
Q2 202414,565$1.17M<0.1%00.0%UnchangedHolders
Q1 202414,565$1.16M<0.1%−735−4.8%ReducedHolders
Q4 202315,300$1.22M<0.1%00.0%UnchangedHolders
Q3 202315,300$1.07M<0.1%+4,250+38.5%AddedHolders
Q2 202311,050$794.1K<0.1%+1,100+11.1%AddedHolders
Q1 20239,950$613.7K<0.1%+550+5.9%AddedHolders
Q4 20229,400$725.0K<0.1%+750+8.7%AddedHolders
Q3 20228,650$386.0K<0.1%−2,670−23.6%ReducedHolders
Q2 202211,320$434.0K<0.1%00.0%UnchangedHolders
Q1 202211,320$469.0K<0.1%00.0%UnchangedHolders
Q4 202111,320$428.0K<0.1%+11,320NewHolders
Q3 20210$00.0%−11,597−100.0%Sold outHolders
Q2 202111,597$782.0K<0.1%−6,485−35.9%ReducedHolders
Q1 202118,082$1.02M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.